Publications by authors named "Emily Aspasia Karanges"
Objectives: To investigate the extent and nature of pharmaceutical industry payments related to fertility and assisted reproduction in Australia.
Design And Setting: This retrospective observational study employed four databases compiled from publicly available pharmaceutical industry transparency reports on educational event sponsorship (October 2011-April 2018), payments to healthcare professionals (October 2015-April 2018) and patient group support (January 2013-December 2017). Analyses were restricted to fertility-related payments by two major manufacturers of fertility medicines in Australia: Merck Serono and Merck, Sharp and Dohme (MSD).